Logo image of SPA.BR

SPADEL SA (SPA.BR) Stock Fundamental Analysis

Europe - Euronext Brussels - EBR:SPA - BE0003798155 - Common Stock

228 EUR
+2 (+0.88%)
Last: 12/29/2025, 7:00:00 PM
Fundamental Rating

5

Taking everything into account, SPA scores 5 out of 10 in our fundamental rating. SPA was compared to 26 industry peers in the Beverages industry. SPA scores excellent points on both the profitability and health parts. This is a solid base for a good stock. SPA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

SPA had positive earnings in the past year.
SPA had a positive operating cash flow in the past year.
In the past 5 years SPA has always been profitable.
SPA had a positive operating cash flow in each of the past 5 years.
SPA.BR Yearly Net Income VS EBIT VS OCF VS FCFSPA.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

1.2 Ratios

The Return On Assets of SPA (8.70%) is better than 92.31% of its industry peers.
SPA's Return On Equity of 13.47% is fine compared to the rest of the industry. SPA outperforms 73.08% of its industry peers.
SPA has a better Return On Invested Capital (11.79%) than 84.62% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SPA is in line with the industry average of 7.67%.
The last Return On Invested Capital (11.79%) for SPA is above the 3 year average (8.57%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 8.7%
ROE 13.47%
ROIC 11.79%
ROA(3y)6.19%
ROA(5y)6.45%
ROE(3y)9.43%
ROE(5y)10.16%
ROIC(3y)8.57%
ROIC(5y)9.02%
SPA.BR Yearly ROA, ROE, ROICSPA.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

The Profit Margin of SPA (10.90%) is better than 65.38% of its industry peers.
In the last couple of years the Profit Margin of SPA has grown nicely.
SPA's Operating Margin of 13.14% is on the low side compared to the rest of the industry. SPA is outperformed by 65.38% of its industry peers.
In the last couple of years the Operating Margin of SPA has grown nicely.
The Gross Margin of SPA (39.57%) is worse than 69.23% of its industry peers.
In the last couple of years the Gross Margin of SPA has remained more or less at the same level.
Industry RankSector Rank
OM 13.14%
PM (TTM) 10.9%
GM 39.57%
OM growth 3Y-0.5%
OM growth 5Y1.58%
PM growth 3Y4.62%
PM growth 5Y3.65%
GM growth 3Y1.4%
GM growth 5Y1.36%
SPA.BR Yearly Profit, Operating, Gross MarginsSPA.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SPA is still creating some value.
The number of shares outstanding for SPA remains at a similar level compared to 1 year ago.
Compared to 5 years ago, SPA has about the same amount of shares outstanding.
Compared to 1 year ago, SPA has a worse debt to assets ratio.
SPA.BR Yearly Shares OutstandingSPA.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
SPA.BR Yearly Total Debt VS Total AssetsSPA.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

SPA has an Altman-Z score of 5.53. This indicates that SPA is financially healthy and has little risk of bankruptcy at the moment.
SPA has a better Altman-Z score (5.53) than 100.00% of its industry peers.
The Debt to FCF ratio of SPA is 0.13, which is an excellent value as it means it would take SPA, only 0.13 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.13, SPA belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
A Debt/Equity ratio of 0.01 indicates that SPA is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.01, SPA belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.13
Altman-Z 5.53
ROIC/WACC1.5
WACC7.86%
SPA.BR Yearly LT Debt VS Equity VS FCFSPA.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.3 Liquidity

SPA has a Current Ratio of 1.88. This is a normal value and indicates that SPA is financially healthy and should not expect problems in meeting its short term obligations.
SPA has a Current ratio of 1.88. This is in the better half of the industry: SPA outperforms 69.23% of its industry peers.
SPA has a Quick Ratio of 1.70. This is a normal value and indicates that SPA is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 1.70, SPA belongs to the best of the industry, outperforming 96.15% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.88
Quick Ratio 1.7
SPA.BR Yearly Current Assets VS Current LiabilitesSPA.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

3

3. Growth

3.1 Past

SPA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.61%, which is quite impressive.
Measured over the past years, SPA shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.75% on average per year.
SPA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.40%.
SPA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.92% yearly.
EPS 1Y (TTM)26.61%
EPS 3Y15.47%
EPS 5Y8.75%
EPS Q2Q%10.68%
Revenue 1Y (TTM)11.4%
Revenue growth 3Y10.37%
Revenue growth 5Y4.92%
Sales Q2Q%10.81%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SPA.BR Yearly Revenue VS EstimatesSPA.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 21.69, which indicates a rather expensive current valuation of SPA.
The rest of the industry has a similar Price/Earnings ratio as SPA.
The average S&P500 Price/Earnings ratio is at 26.84. SPA is around the same levels.
Industry RankSector Rank
PE 21.69
Fwd PE N/A
SPA.BR Price Earnings VS Forward Price EarningsSPA.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SPA is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, SPA is valued a bit more expensive than the industry average as 69.23% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 23.83
EV/EBITDA 10.74
SPA.BR Per share dataSPA.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

The decent profitability rating of SPA may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.48
EPS Next 2YN/A
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.98%, SPA is not a good candidate for dividend investing.
With a Dividend Yield of 0.98, SPA pays less dividend than the industry average, which is at 2.92. 84.62% of the companies listed in the same industry pay a better dividend than SPA!
With a Dividend Yield of 0.98, SPA pays less dividend than the S&P500 average, which is at 2.00.
Industry RankSector Rank
Dividend Yield 0.98%

5.2 History

The dividend of SPA has a limited annual growth rate of 1.92%.
Dividend Growth(5Y)1.92%
Div Incr Years2
Div Non Decr Years2
SPA.BR Yearly Dividends per shareSPA.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

SPA pays out 30.45% of its income as dividend. This is a sustainable payout ratio.
The dividend of SPA is growing, but earnings are growing more, so the dividend growth is sustainable.
DP30.45%
EPS Next 2YN/A
EPS Next 3YN/A
SPA.BR Yearly Income VS Free CF VS DividendSPA.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
SPA.BR Dividend Payout.SPA.BR Dividend Payout, showing the Payout Ratio.SPA.BR Dividend Payout.PayoutRetained Earnings

SPADEL SA

EBR:SPA (12/29/2025, 7:00:00 PM)

228

+2 (+0.88%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)09-01 2025-09-01
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners97.59%
Ins Owner ChangeN/A
Market Cap946.20M
Revenue(TTM)399.96M
Net Income(TTM)43.62M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.98%
Yearly Dividend2.2
Dividend Growth(5Y)1.92%
DP30.45%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 21.69
Fwd PE N/A
P/S 2.37
P/FCF 23.83
P/OCF 13.8
P/B 2.92
P/tB 4.43
EV/EBITDA 10.74
EPS(TTM)10.51
EY4.61%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)9.57
FCFY4.2%
OCF(TTM)16.53
OCFY7.25%
SpS96.38
BVpS78.04
TBVpS51.43
PEG (NY)N/A
PEG (5Y)2.48
Graham Number135.85
Profitability
Industry RankSector Rank
ROA 8.7%
ROE 13.47%
ROCE 14.63%
ROIC 11.79%
ROICexc 19.37%
ROICexgc 39.13%
OM 13.14%
PM (TTM) 10.9%
GM 39.57%
FCFM 9.93%
ROA(3y)6.19%
ROA(5y)6.45%
ROE(3y)9.43%
ROE(5y)10.16%
ROIC(3y)8.57%
ROIC(5y)9.02%
ROICexc(3y)13.94%
ROICexc(5y)13.81%
ROICexgc(3y)32.94%
ROICexgc(5y)32.52%
ROCE(3y)10.63%
ROCE(5y)11.39%
ROICexgc growth 3Y14.92%
ROICexgc growth 5Y8.53%
ROICexc growth 3Y13.66%
ROICexc growth 5Y8.37%
OM growth 3Y-0.5%
OM growth 5Y1.58%
PM growth 3Y4.62%
PM growth 5Y3.65%
GM growth 3Y1.4%
GM growth 5Y1.36%
F-Score8
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.13
Debt/EBITDA 0.04
Cap/Depr 125.99%
Cap/Sales 7.22%
Interest Coverage 73.39
Cash Conversion 90.89%
Profit Quality 91.05%
Current Ratio 1.88
Quick Ratio 1.7
Altman-Z 5.53
F-Score8
WACC7.86%
ROIC/WACC1.5
Cap/Depr(3y)93.53%
Cap/Depr(5y)93.22%
Cap/Sales(3y)5.83%
Cap/Sales(5y)6.29%
Profit Quality(3y)136.29%
Profit Quality(5y)124.06%
High Growth Momentum
Growth
EPS 1Y (TTM)26.61%
EPS 3Y15.47%
EPS 5Y8.75%
EPS Q2Q%10.68%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.4%
Revenue growth 3Y10.37%
Revenue growth 5Y4.92%
Sales Q2Q%10.81%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y29.43%
EBIT growth 3Y9.82%
EBIT growth 5Y6.57%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y98.09%
FCF growth 3Y16.51%
FCF growth 5Y18.57%
OCF growth 1Y85.3%
OCF growth 3Y13.89%
OCF growth 5Y11.4%

SPADEL SA / SPA.BR FAQ

What is the ChartMill fundamental rating of SPADEL SA (SPA.BR) stock?

ChartMill assigns a fundamental rating of 5 / 10 to SPA.BR.


Can you provide the valuation status for SPADEL SA?

ChartMill assigns a valuation rating of 1 / 10 to SPADEL SA (SPA.BR). This can be considered as Overvalued.


Can you provide the profitability details for SPADEL SA?

SPADEL SA (SPA.BR) has a profitability rating of 7 / 10.


Can you provide the dividend sustainability for SPA stock?

The dividend rating of SPADEL SA (SPA.BR) is 3 / 10 and the dividend payout ratio is 30.45%.